XML 23 R32.htm IDEA: XBRL DOCUMENT v3.19.3
Stock Award Programs (Tables)
9 Months Ended
Sep. 30, 2019
Share-based Payment Arrangement [Abstract]  
Schedule of nonvested restricted stock shares activity
    2019           2018        
NON-VESTED AWARDS   (Unaudited)    
Non-vested awards outstanding, January 1,     300,000             -        
Granted (+)     662,740       (1 )     980,851       (1 )
Cancelled (-)     50,000       (2 )     -          
Vested (-)     405,240       (3 )     680,851       (1 )
Non-vested awards outstanding, September 30,     507,500               300,000          
                                 
Weighted-average remaining contractual life (in years)     8.24               0.8          
                                 
Unamortized RSA compensation expense   $ 182,586             $ 153,418          
                                 
Aggregate intrinsic value of RSAs non-vested, September 30   $ 157,325             $ 138,000          
                                 
Aggregate intrinsic value of RSAs vested, September 30   $ 171,867             $ 320,000          

 

(1) During the nine month period ended September 30, 2019, the Company granted 662,740 RSAs, of which i) 238,572 of RSAs were awarded to members of the Company’s board of directors as part of their annual board retainer fee that had a grant date fair value of $100,200 and vested during the period, and ii) 424,168 of RSAs were awarded to key employees tied to the attainment of certain financial goals as outlined by the Company’s Compensation Committee of the Board of Directors that had a grant date fair value of $254,501. During the nine month period ended September 30, 2018, the Company granted 980,851 RSAs, of which i) 300,000 of RSAs were awarded as part of additional compensation plan to align key employees with the Company’s long term financial goals, and ii) 680,851 were awarded to members of the Company’s board of directors as part of their annual board retainer fee and vested during the period.

 

(2) There were 50,000 RSAs that were cancelled during the nine month period ended September 30, 2019. There were no RSAs cancelled or expired during the nine month period ended September 30, 2018.

 

(3) During the nine month period ended September 30, 2019, 405,240 RSAs vested.

 

Schedule of nonvested share activity
    2019     2018  
                Weighted                 Weighted  
                Average                 Average  
                Grant Date                 Grant Date  
NON-VESTED AWARDS   Shares           Fair Value     Shares           Fair Value  
     (Unaudited)  
Non-vested balances, January 1,     2,067,503           $ 0.36       2,685,004           $ 0.35  
Granted (+)     25,000       (1 )   $ 0.15       125,000       (1 )   $ 0.25  
Cancelled (-)     80,001       (2 )   $ 0.34       50,000       (2 )   $ 0.32  
Vested/Excercised (-)     837,497             $ 0.34       312,500       (3 )   $ 0.26  
Non-vested balances, September 30,     1,175,005             $ 0.37       2,447,504             $ 0.35  
Schedule of outstanding and exercercisable share activity
    2019     2018  
                Weighted                 Weighted  
                Average                 Average  
OUTSTANDING AND EXERCISABLE AWARDS   Shares           Exercise Price     Shares           Exercise Price  
     (Unaudited)  
Awards outstanding, January 1,     4,013,334           $ 0.58       4,173,334           $ 0.60  
Granted (+)     25,000       (1 )   $ 0.41       125,000       (1 )   $ 0.50  
Cancelled (-)     530,000       (2 )   $ 0.55       110,000       (2 )   $ 1.11  
Exercised (-)     -               -       50,000       (3 )   $ 0.44  
Awards outstanding, September 30,     3,508,334             $ 0.59       4,138,334             $ 0.58  
                                                 
Awards vested and expected to vest,                                                
September 30,     3,165,153             $ 0.59       3,547,472             $ 0.58  
                                                 
Awards outstanding and exercisable,                                                
September 30,     2,333,329             $ 0.58       1,690,830             $ 0.56  

 

(1) During the nine month period ended September 30, 2019, there were non-qualified stock option (NQSO) grants of 25,000 granted to a non-employee as compensation for investor relations services. This stock award grant was valued using a Black-Scholes model that assumed a 1-year vesting period, 2-year option term, a risk free rate of 2.5%, volatility of 64.6%, no assumed dividend yield, and a forfeiture rate estimate of 1.2%. During the nine month period ended September 30, 2018, there were non-qualified stock option (NQSO) grants of 125,000, as further described below:

 

Employees. During the nine month period ended September 30, 2018, the Company granted 75,000 non-qualified stock options as part of an additional compensation to align a key employee with the Company’s long term financial goals. This stock award grant was valued using a Black-Scholes model that assumed a 3-year vesting period, 5-year option term, a risk free rate of 2.7%, volatility of 66.7%, no assumed dividend yield, and a forfeiture rate estimate of 4.8%.

 

Non-Employees. During the nine month period ended September 30, 2018, the Company granted 50,000 non-qualified stock options as payment for a portion of the annual retainer paid to its public investor relations firm. This stock award grant was valued using a Black-Scholes model that assumed a 1-year vesting period, 2-year option term, a risk free rate of 2.6%, volatility of 69.5%, no assumed dividend yield, and a forfeiture rate estimate of 10.3%.

 

(2) During the nine month period ended September 30, 2019, there were 530,000 NQSOs that were cancelled, of which 80,001 were unvested, related to voluntary employee terminations.

 

(3) The total intrinsic value of stock options exercised during the nine month period ended September 30, 2018 was approximately $5,500.

 

Schedule of share-based compensation
   THREE MONTHS ENDED  NINE MONTHS ENDED
   SEPTEMBER 30  SEPTEMBER 30
   2019  2018  2019  2018
   (Unaudited)
Restricted stock compensation expense  $91,826   $202,664   $289,426   $370,582 
Non-qualified option stock compensation expense   71,625    70,073    247,402    222,493 
                     
Total share-based compensation before taxes  $163,451   $272,737   $536,828   $593,075